Try our beta test site
225 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
1 Recruiting The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Device: C2 videos;   Procedure: colonoscopy
2 Recruiting Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Condition: Colitis, Ulcerative
Intervention: Other: No Intervention
3 Recruiting Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
4 Recruiting GSK2982772 Study in Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: GSK2982772;   Drug: Placebo
5 Recruiting Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: SB012;   Drug: Placebo
6 Not yet recruiting Mercaptopurine Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Mercaptopurine (Purinethol);   Drug: Placebo;   Drug: Mesalamine;   Drug: Prednisone
7 Not yet recruiting Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab IV
8 Recruiting Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention:
9 Recruiting An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: LYC-30937-EC;   Drug: Placebo
10 Recruiting Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: LYC-30937-EC
11 Recruiting Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: PF-06480605
12 Recruiting An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab 300 mg
13 Recruiting Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
14 Recruiting An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Adalimumab placebo;   Drug: Adalimumab;   Drug: Vedolizumab placebo
15 Recruiting Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab IV 300 mg;   Drug: Placebo IV;   Drug: Vedolizumab SC 108 mg;   Drug: Placebo SC
16 Recruiting A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Condition: Colitis, Ulcerative
Interventions: Drug: Etrolizumab;   Drug: Placebo
17 Not yet recruiting Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
Condition: Colitis,Ulcerative
Interventions: Other: Discontinuation of anti-TNF treatment;   Other: Continuation of anti-TNF treatment
18 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
19 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
20 Not yet recruiting Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: berberine;   Drug: regular treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.